Myomo Announces Participation in Upcoming Investor Conferences
BURLINGTON, Mass. (May 14, 2026) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced its participation in two upcoming investor conferences. On May 20, Myomo’s President and Chief Executive Officer Paul Gudonis and Chief […]
Myomo Appoints Joseph M. Manko to its Board of Directors
BURLINGTON, MA. (May 13, 2026) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Joseph M. (“Joe”) Manko Jr. as a director effective May 9, 2026, to serve until the 2027 […]
Myomo Reports First Quarter 2026 Financial and Operating Results
Revenue of $10.1 million with 49% of first quarter revenue from recurring patient sources MyoPro® orders received during the quarter were up 12% year-over-year Expanded gross margin, lower operating expenses and narrowed net loss Conference call begins at 4:30pm Eastern time today BURLINGTON, Mass. (May 7, 2026) – Myomo, Inc. (NYSE American: MYO) […]
Myomo Announces Availability of MyoPro at Ottobock Care Clinics in the U.S.
Burlington, Mass. (May 4, 2026) – Myomo, Inc. (NYSE American: MYO) a wearable medical robotics company and manufacturer of the MyoPro® powered arm brace announces expanded access to the MyoPro device through Ottobock Care clinics nationwide. Ottobock Care will offer the MyoPro through its clinics across the country, helping individuals with upper extremity impairment caused […]
Myomo to Report First Quarter 2026 Financial Results on May 7
BURLINGTON, Mass. (May 1, 2026) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the first quarter ended March 31, 2026 on Thursday, May 7, 2026. Management […]
Myomo Introduces Myomo Mobile App to Enhance Clinical Workflow and Patient Engagement
BURLINGTON, Mass. — April 20, 2026 — Myomo, Inc. (NYSE American: MYO), a wearable medical robotics company that offers increased functionality for people with neurological disorders and upper-limb paralysis, announces the launch of the Myomo® Mobile App, a new digital tool designed to support clinicians and patients throughout the MyoPro® experience. The Myomo Mobile App is […]
Myomo Appoints William J Febbo to its Board of Directors
BURLINGTON, MA. (April 16, 2026) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of William “Will” Febbo as a director effective April 14, 2026, to serve until the 2028 annual meeting […]
Myomo and Elevance Health Agree to Contract for Multi-State Network Participation
BURLINGTON, Mass. (March 9, 2026) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced today it has entered into its first among a series of expected network participation agreements with Elevance Health. The contracts, which include […]
Myomo Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
Fourth quarter revenue of $11.4 million, full year revenue of $40.9 million 42% of fourth quarter revenue from recurring patient sources Record 241 authorizations and orders in the quarter Introduces 2026 revenue guidance of $43 million to $46 million as Company emphasizes recurring sources of revenue Conference call begins today at 4:30pm Eastern […]
Myomo to Report Fourth Quarter 2025 Financial Results on March 9
BURLINGTON, Mass. (March 2, 2026) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the fourth quarter and year ended December 31, 2025 on Monday, March 9, […]